Stocktoria
GLAUKOS Corp GKOS
NYSE · XNYS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2015-06-25
GLAUKOS Corp statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 55.7% | 75.5% | 76.0% | 75.6% | 77.3% |
| Operating margin | -39.3% | -31.9% | -40.9% | -29.1% | -11.2% |
| Net margin | -37.0% | -38.2% | -42.8% | -35.1% | -16.9% |
| FCF margin | -4.4% | -17.6% | -24.8% | -22.4% | -7.8% |
| Return on assets | -21.0% | -15.0% | -14.3% | -9.9% | -4.7% |
| Return on equity | -28.6% | -19.1% | -29.2% | -18.7% | -8.4% |
| Current ratio | 4.69 | 5.99 | 5.34 | 6.13 | 7.67 |
| Revenue growth | 32.3% | 21.9% | 11.3% | -3.8% | 30.7% |
Source: SEC EDGAR filings · CIK 0001192448 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.